Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

The presence of tumor immune infiltrating cells (TILs), particularly CD8(+) T-cells, is a robust predictor of outcome in patients with colorectal cancer (CRC). We revisited TIL abundance specifically in patients with microsatellite stable (MSS) CRC without evidence of lymph node or metastatic spread...

Descripción completa

Detalles Bibliográficos
Autores principales: Millen, Rosemary, Malaterre, Jordane, Cross, Ryan S., Carpinteri, Sandra, Desai, Jayesh, Tran, Ben, Darcy, Phillip, Gibbs, Peter, Sieber, Oliver, Zeps, Nikolajs, Waring, Paul, Fox, Stephen, Pereira, Lloyd, Ramsay, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006930/
https://www.ncbi.nlm.nih.gov/pubmed/27622014
http://dx.doi.org/10.1080/2162402X.2016.1149667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006930/
https://www.ncbi.nlm.nih.gov/pubmed/27622014
http://dx.doi.org/10.1080/2162402X.2016.1149667

Ejemplares similares